Blair Leavitt, MDCM, FRCPC
University of British Columbia
Dr. Leavitt is a Huntington’s disease (HD) neurologist, Professor in the Department of Medical Genetics at the University of British Columbia (UBC), an established HD clinical trial investigator, and the Director of Research at the UBC Centre for HD in Vancouver. Dr. Leavitt’s laboratory and clinical research focuses on developing new therapies for devastating neurodegenerative diseases such as HD, FTD and ALS and also includes research programs searching for clinical biomarkers in HD and identifying new genetic causes of ataxia, epilepsy, neurodevelopmental disorders, and autism. Dr. Leavitt is a senior scientist at the Centre for Molecular Medicine and therapeutics.
NOTE: If no session is listed above, this individual is a Chair or Co-chair of a session(s). Please see the individual session listings found in the Program for a full list of session participants.